Skip to main content

Table 6 Relevancy feedback performance in terms of WSS@95% on DERP systematic review collections

From: Improving reference prioritisation with PICO recognition

 [120][121]LRPICOΔ
ACE Inhibitors74.3*82.774.774.4-0.3
ADHD67.9*82.167.568.91.4
Antihistamines*24.517.7-1.7-1.9-0.1
Atypical Antipsychotics18.0*33.618.020.52.5
Beta Blockers65.0*68.554.755.71.1
Calcium Channel Blockers17.312.8*47.647.1-0.5
Estrogens22.628.536.6*39.12.4
NSAIDS*77.464.160.963.12.2
Opioids9.017.419.5*34.114.6
Oral Hypoglycemic13.5*15.96.99.22.3
Proton Pump Inhibitors19.721.0*21.218.3-2.9
Skeletal Muscle Relaxants*58.629.925.932.46.5
Statins27.8*43.742.943.30.3
Triptans39.6*54.134.352.418.1
Urinary Incontinence20.841.644.8*46.41.6
Average37.140.936.940.23.3
  1. Δindicates the change between adding the PICO features to the baseline logistic regression classifier (LR)
  2. *indicate best performance per review